Efficacy and safety of a L-dopa delivery and monitoring medical device
Objective: The objective of this study is to evaluate algorithms in a medical device for l-dopa delivery and monitoring. This wearable medical device will measure…FBOX07 mutation with juvenile parkinsonism and behavioral disorders
Objective: FBX07 (PARK15) mutations cause juvenile parkinsonism with autosomal ressesive inheritance. Juvenile parkinsonism, pyramidal tract signs and atypical symptoms such as dystonia, chorea, behavioral disturbances,…Sleep related disorders in subtypes of patients with Parkinson’s disease in the Tomsk region, Russia
Objective: To describe sleep related disorders (SRD) in Tremor Dominant (TD) and Akinetic Rigid (AR) patients with Parkinson's disease in (PwPD) subtypes evaluated at Movement…Incidence of fragility fractures in people with parkinsonism [PwP] – A 5 year retrospective observational study
Objective: The objective of this study is to estimate the incidence of fragility fractures in people with Parkinson's (PwP) over a 5 year period and…Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging
Objective: To describe the diagnostic reliability of the triad of clinical symptoms compared to the uptake of 18 F-DOPA PET-CT fusion MRI scan. To compare…Are clinical certainty ratings helpful in the diagnosis of Parkinson’s disease?
Objective: To determine whether clinical certainty ratings are helpful in predicting pathologically proven PD. Background: Clinical diagnostic criteria for PD rely on rest tremor, bradykinesia,…
- « Previous Page
- 1
- …
- 5
- 6
- 7